Neoadjuvant Talazoparib in Patients With Germline BRCA1/2 Mutation-Positive, Early-Stage Triple-Negative Breast Cancer: Results of a Phase II Study.

Jennifer K LittonJ Thaddeus BeckJason M JonesJay AndersenJoanne L BlumLida A MinaRaymond BrigMichael DansoYuan YuanAntonello AbbattistaKay NoonanAlexander NiyazovJayeta ChakrabartiAkos CzibereWilliam F SymmansMelinda L Telli

Published in: The oncologist (2023)

NCT03499353.

Keyphrases

phase ii study
locally advanced
early stage
rectal cancer
neoadjuvant chemotherapy
squamous cell carcinoma
radiation therapy
open label
dna repair
sentinel lymph node
lymph node
breast cancer risk
clinical trial